Skip to content

    GEMAROMA

    GEMAROMA
    Chemicals·22 May 2026
    Management Summary

    Gem Aromatics Limited reported a quarter of sequential improvement in Q4 FY26, with significant QoQ growth in revenue and EBITDA, driven by better volumes and price realization. The company commenced commercial production at its new Dahej facility and achieved a high sustainability rating for its Silvassa plant. However, geopolitical issues caused delays in phenol derivative production, and U.S. tariffs led to a year-on-year decline in Q4 revenues for mint exports, impacting overall performance.

    Highlights

    5

    • Consolidated revenue increased 40% QoQ to INR 110 crores from INR 79 crores in Q3 FY26, driven by better volumes and improved price realization.

    • Consolidated EBITDA grew 124% QoQ to INR 16 crores from INR 7 crores in Q3 FY26, with margins improving to 14.2%.

    • Commercial production of Gemcool 5 and Safranal commenced at the Dahej greenfield facility on February 26, 2026, strengthening the integrated portfolio.

    • The Silvassa plant received the EcoVadis Platinum sustainability rating, placing the company among top companies globally for sustainability performance.

    • Gross margins and EBITDA margins moved closer to normalized levels, supported by improving demand trends and healthier product mix.

    Concerns

    3

    • Geopolitical developments led to elevated raw material prices for key petrochemicals like phenol, impacting near-term production timelines for phenol-based derivatives.

    • Q4 FY26 revenues were significantly lower than Q4 FY25, primarily due to a volume dip in mint exports to the U.S. market caused by tariffs.

    • Profitability was impacted by higher depreciation following the capitalization of a substantial portion of capex incurred towards the Dahej facility.

    Key financials

    Single quarter

    08 metrics
    1. 01Revenue (Standalone)₹112 Cr+33.3%QoQ
    2. 02Revenue (Consolidated)₹110 Cr+39.2%QoQ
    3. 03Gross Profit (Consolidated)₹34 Cr+70%QoQ
    4. 04Gross Profit Margin (Consolidated)30.5%
    5. 05EBITDA (Consolidated)₹16 Cr+128.6%QoQ

    Capital allocation

    1
    high confidence
    CategoryHeadline
    Capex

    ₹270 crores

    Guidance & targets

    5
    CategoryTargetPriority
    Revenue
    Consolidated Turnover
    INR 1,100 crores
    		Medium
    Profitability
    EBITDA Margins
    16-18%
    		Medium
    Profitability
    EBITDA Margins
    16-18%
    		Medium
    Revenue Potential
    Peak Potential Revenue from New Dahej Unit
    INR 800 crores
    		High
    Asset Efficiency
    Asset Turn for Dahej Capex
    3-3.5 times
    		High

    Dahej facility utilization ramp-up

    H2 FY27
    CurrentPlant went live in April 2026, low utilization currently
    TargetImproved utilization numbers, especially by H2 FY27

    Why it matters

    Ramping up utilization at the Dahej facility is key to realizing the INR 800 crores peak revenue potential and improving operating leverage.

    Well, look, due to the geopolitical uncertainty and the ramp-up of Krystal which is about to happen this year, we have cognizantly not given a guidance for the year, but closer to, probably H2, we can give you a good utilization number as the plant ramps up.

    How to verify

    key_financials.metrics[label='Capacity Utilization']

    Risks & concerns

    3
    RiskSeverity

    Geopolitical developments and raw material volatility

    Ongoing geopolitical developments are impacting availability and pricing of key petrochemical raw materials like phenol, leading to elevated prices and affecting near-term production timelines for phenol-based derivatives. — Management acknowledged

    high

    Impact of U.S. tariffs on mint exports

    U.S. tariffs caused a significant volume dip in mint exports, which historically contributed heavily to Q4 revenues, leading to a year-on-year decline in Q4 FY26. — Management acknowledged

    medium

    Higher depreciation impacting profitability

    Profitability during the quarter was impacted by higher depreciation following the capitalization of a substantial portion of capex incurred towards the Dahej facility. — Management acknowledged

    low

    Q&A highlights

    6

    “Well, look, due to the geopolitical uncertainty and the ramp-up of Krystal which is about to happen this year, we have cognizantly not given a guidance for the year, but closer to, probably H2, we can give you a good utilization number as the plant ramps up.”

    Management provided a peak revenue potential for the new Dahej unit but deferred specific utilization guidance due to external uncertainties, indicating a cautious ramp-up.

    asked by Deepak Poddar

    2 min read5 chapters

    Detailed Narrative

    01

    Q4 FY26 Performance Overview and Sequential Improvement

    Gem Aromatics Limited reported a quarter of sequential improvement in Q4 FY26. Standalone revenue from operations increased 34% QoQ to INR 112 crores, while consolidated revenue grew 40% QoQ to INR 110 crores. This improvement was primarily driven by better volumes, improved price realization, and a healthier product mix. Consolidated EBITDA saw a significant 124% QoQ growth to INR 16 crores, with EBITDA margins reaching 14.2%, moving closer to normalized levels.

    02

    Dahej Greenfield Facility and Product Diversification

    The company made significant progress at its Dahej greenfield facility, with commercial production of Gemcool 5 and Safranal commencing on February 26, 2026. This strengthens the integrated portfolio across cooling agents, Safranal, clove oil, eugenol, and clove derivatives. Out of the approximately INR 270 crores planned capex for the Dahej project, nearly INR 260 crores has already been incurred and substantially capitalized, contributing to higher depreciation impacting current profitability.

    03

    Impact of Geopolitical Issues and U.S. Tariffs

    Geopolitical developments continue to impact the availability and pricing of key petrochemical raw materials like phenol, leading to elevated raw material prices and affecting near-term production timelines for phenol-based derivatives. Additionally, Q4 FY26 revenues were significantly lower year-on-year compared to Q4 FY25, primarily due to a substantial volume dip in mint exports to the U.S. market, which was caused by tariffs and delayed clarity on tariff situations until late February 2026.

    04

    Strategic Focus and Future Outlook

    The company remains focused on improving utilization levels at the Dahej facility, scaling high-value specialty products, and strengthening long-term customer partnerships. Management expects operating leverage benefits to further support margin and profitability going forward⏳. For the next year (FY27), the company targets a consolidated turnover of INR 1,100 crores and EBITDA margins in the range of 16-18%, with a similar EBITDA target for FY28.

    05

    Cooling Agents Business Strategy and Sustainability Recognition

    The decision to enter the cooling agents segment was driven by forward integration from the mint vertical, global customer demand in oral care, and its status as a tariff-exempt product for India to U.S. exports. The company believes this segment has strong growth potential, both as a booster in formulations and for partial menthol replacement. Furthermore, the Silvassa plant received the EcoVadis Platinum sustainability rating, highlighting the company's commitment to responsible manufacturing practices.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.